BBIO vs SYF
BridgeBio Pharma Inc (BBIO) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
SYF (SYF) common stock.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
SYF does not have a complete income-statement cache yet.
BBIO currently screens at market cap $13.24B. SYF currently screens at market cap $0.
Not investment advice. Open the BBIO and SYF stock pages for the full models.
Not investment advice.